Compare $FBLG vs $VSBC | Chartloom

Compare

$FBLG vs $VSBC

Fibrobiologics Inc · Vitaspring Biomedical Co. Ltd

FBLG

Fibrobiologics Inc

VSBC

Vitaspring Biomedical Co. Ltd

Compare $FBLG vs $VSBC

Comparing Fibrobiologics Inc and Vitaspring Biomedical Co. Ltd

FBLGFibrobiologics Inc

VSBCVitaspring Biomedical Co. Ltd

FBLGFibrobiologics Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-76.4%

52W performance

-88.8%

FCF yield

-215.4%

VSBCVitaspring Biomedical Co. Ltd

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

0.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBLG

VSBC

Detailed metrics comparison

FBLG

Fibrobiologics Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

FBLG$7M

VSBC$7M

Enterprise Value

FBLG$3M

VSBC$9M

Price

FBLG$1.13

VSBC$0.00

P/E Ratio

FBLGN/A

VSBCN/A

P/S Ratio

FBLG0.00x

VSBC0.99x

EV/Sales

FBLG0.00x

VSBC0.99x

EV/EBITDA

FBLG0.00x

VSBC4.29x

P/B Ratio

FBLG1.78x

VSBC3.92x

P/FCF Ratio

FBLGN/A

VSBC765.53x

EV/FCF

FBLG-0.24x

VSBC1,044.32x

PEG Ratio

FBLGN/A

VSBCN/A

Forward P/E (NTM)

FBLGN/A

VSBCN/A

Forward P/S (NTM)

FBLGN/A

VSBCN/A

Revenue (TTM)

FBLG$0

VSBC$0

Revenue Growth (YoY)

FBLGN/A

VSBCN/A

Forward Rev Growth

FBLG227.6%

VSBC0.0%

Gross Margin (TTM)

FBLG0.0%

VSBC39.3%

Operating Margin (TTM)

FBLG0.0%

VSBC23.4%

EBITDA Margin (TTM)

FBLG0.0%

VSBC0.0%

Net Margin (TTM)

FBLG0.0%

VSBC18.2%

FCF Margin (TTM)

FBLGN/A

VSBCN/A

Net Income (TTM)

FBLG$-18M

VSBC$-456K

FCF (TTM)

FBLG$-15M

VSBC$9K

EPS (TTM)

FBLG-$2.89

VSBC-$0.00

ROE (TTM)

FBLG-53678.0%

VSBC70.0%

ROA (TTM)

FBLG-22512.0%

VSBC-211240.0%

ROIC (TTM)

FBLG-39304.0%

VSBC70.0%

Cash

FBLG$4M

VSBC$13K

Debt

FBLG$124K

VSBC$2M

Net Cash/Debt

FBLG$3M

VSBC$-2M

Current Ratio (TTM)

FBLG2.64x

VSBC0.00x

Quick Ratio (TTM)

FBLG2.40x

VSBC0.00x

Debt/Equity (TTM)

FBLG0.03x

VSBC0.00x

Debt/Assets (TTM)

FBLG0.0%

VSBC0.0%

Interest Coverage (TTM)

FBLGN/A

VSBCN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

VSBC0.00x

Beta

FBLG1.79

VSBC-1.47

52W Performance

FBLG-88.8%

VSBC-100.0%

YTD Performance

FBLG-76.4%

VSBC-100.0%

% from 52W High

FBLG-89.0%

VSBC-100.0%

% from 52W Low

FBLG82.3%

VSBCN/A

Asset Turnover (TTM)

FBLG0.00x

VSBC2.66x

FCF Yield (TTM)

FBLG-215.4%

VSBC0.1%

Earnings Yield (TTM)

FBLG-264.0%

VSBC-6.9%

Dividend Yield (TTM)

FBLGN/A

VSBCN/A

Rule of 40

FBLG0.0

VSBC0.0

EV/GP/RG

FBLGN/A

VSBCN/A

Ticker research

View FBLG research View VSBC research

Metric	FBLG Fibrobiologics Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$7M	$7M
Enterprise Value	$3M	$9M
Price	$1.13	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.99x
EV/Sales	0.00x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	1.78x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.24x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	227.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$2.89	-$0.00
ROE (TTM)	-53678.0%	70.0%
ROA (TTM)	-22512.0%	-211240.0%
ROIC (TTM)	-39304.0%	70.0%
Financial Health
Cash	$4M	$13K
Debt	$124K	$2M
Net Cash/Debt	$3M	$-2M
Current Ratio (TTM)	2.64x	0.00x
Quick Ratio (TTM)	2.40x	0.00x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	-1.47
52W Performance	-88.8%	-100.0%
YTD Performance	-76.4%	-100.0%
% from 52W High	-89.0%	-100.0%
% from 52W Low	82.3%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.66x
FCF Yield (TTM)	-215.4%	0.1%
Earnings Yield (TTM)	-264.0%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBLG research	View VSBC research

Valuation

P/S Ratio

FBLG

0.00x

VSBC

0.99x

EV/FCF

FBLG

-0.24x

VSBC

1,044.32x

Growth & revenue

Forward Revenue Growth

FBLG

227.6%

VSBC

0.0%

Profitability & performance

Gross Margin

VSBC

39.3%

FBLG

0.0%

ROE

VSBC

70.0%

FBLG

-53678.0%

FCF Yield %

VSBC

0.1%

FBLG

-215.4%

52-Week Performance

FBLG

-88.8%

VSBC

-100.0%

Detailed metrics comparison

FBLG

Fibrobiologics Inc

VSBC

Vitaspring Biomedical Co. Ltd

Market Cap

FBLG$7M

VSBC$7M

Enterprise Value

FBLG$3M

VSBC$9M

Price

FBLG$1.13

VSBC$0.00

P/E Ratio

FBLGN/A

VSBCN/A

P/S Ratio

FBLG0.00x

VSBC0.99x

EV/Sales

FBLG0.00x

VSBC0.99x

EV/EBITDA

FBLG0.00x

VSBC4.29x

P/B Ratio

FBLG1.78x

VSBC3.92x

P/FCF Ratio

FBLGN/A

VSBC765.53x

EV/FCF

FBLG-0.24x

VSBC1,044.32x

PEG Ratio

FBLGN/A

VSBCN/A

Forward P/E (NTM)

FBLGN/A

VSBCN/A

Forward P/S (NTM)

FBLGN/A

VSBCN/A

Revenue (TTM)

FBLG$0

VSBC$0

Revenue Growth (YoY)

FBLGN/A

VSBCN/A

Forward Rev Growth

FBLG227.6%

VSBC0.0%

Gross Margin (TTM)

FBLG0.0%

VSBC39.3%

Operating Margin (TTM)

FBLG0.0%

VSBC23.4%

EBITDA Margin (TTM)

FBLG0.0%

VSBC0.0%

Net Margin (TTM)

FBLG0.0%

VSBC18.2%

FCF Margin (TTM)

FBLGN/A

VSBCN/A

Net Income (TTM)

FBLG$-18M

VSBC$-456K

FCF (TTM)

FBLG$-15M

VSBC$9K

EPS (TTM)

FBLG-$2.89

VSBC-$0.00

ROE (TTM)

FBLG-53678.0%

VSBC70.0%

ROA (TTM)

FBLG-22512.0%

VSBC-211240.0%

ROIC (TTM)

FBLG-39304.0%

VSBC70.0%

Cash

FBLG$4M

VSBC$13K

Debt

FBLG$124K

VSBC$2M

Net Cash/Debt

FBLG$3M

VSBC$-2M

Current Ratio (TTM)

FBLG2.64x

VSBC0.00x

Quick Ratio (TTM)

FBLG2.40x

VSBC0.00x

Debt/Equity (TTM)

FBLG0.03x

VSBC0.00x

Debt/Assets (TTM)

FBLG0.0%

VSBC0.0%

Interest Coverage (TTM)

FBLGN/A

VSBCN/A

Net Debt/EBITDA (TTM)

FBLG0.00x

VSBC0.00x

Beta

FBLG1.79

VSBC-1.47

52W Performance

FBLG-88.8%

VSBC-100.0%

YTD Performance

FBLG-76.4%

VSBC-100.0%

% from 52W High

FBLG-89.0%

VSBC-100.0%

% from 52W Low

FBLG82.3%

VSBCN/A

Asset Turnover (TTM)

FBLG0.00x

VSBC2.66x

FCF Yield (TTM)

FBLG-215.4%

VSBC0.1%

Earnings Yield (TTM)

FBLG-264.0%

VSBC-6.9%

Dividend Yield (TTM)

FBLGN/A

VSBCN/A

Rule of 40

FBLG0.0

VSBC0.0

EV/GP/RG

FBLGN/A

VSBCN/A

Ticker research

View FBLG research View VSBC research

Metric	FBLG Fibrobiologics Inc	VSBC Vitaspring Biomedical Co. Ltd
Market & Valuation
Market Cap	$7M	$7M
Enterprise Value	$3M	$9M
Price	$1.13	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.99x
EV/Sales	0.00x	0.99x
EV/EBITDA	0.00x	4.29x
P/B Ratio	1.78x	3.92x
P/FCF Ratio	N/A	765.53x
EV/FCF	-0.24x	1,044.32x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	227.6%	0.0%
Profitability
Gross Margin (TTM)	0.0%	39.3%
Operating Margin (TTM)	0.0%	23.4%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	18.2%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-456K
FCF (TTM)	$-15M	$9K
EPS (TTM)	-$2.89	-$0.00
ROE (TTM)	-53678.0%	70.0%
ROA (TTM)	-22512.0%	-211240.0%
ROIC (TTM)	-39304.0%	70.0%
Financial Health
Cash	$4M	$13K
Debt	$124K	$2M
Net Cash/Debt	$3M	$-2M
Current Ratio (TTM)	2.64x	0.00x
Quick Ratio (TTM)	2.40x	0.00x
Debt/Equity (TTM)	0.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.79	-1.47
52W Performance	-88.8%	-100.0%
YTD Performance	-76.4%	-100.0%
% from 52W High	-89.0%	-100.0%
% from 52W Low	82.3%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.00x	2.66x
FCF Yield (TTM)	-215.4%	0.1%
Earnings Yield (TTM)	-264.0%	-6.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBLG research	View VSBC research